Therapeutic

OTHER2 trials

Sponsors

National Heart, Lung, and Blood Institute (NHLBI), Sidney Kimmel Cancer Center at Thomas Jefferson University

Conditions

Breast CarcinomaEndometrial CarcinomaMyelodysplastic Syndromes (MDS)Prostate Carcinosarcoma

Unknown Phase

The National Myelodysplastic Syndromes (MDS) Study

CompletedNCT02775383

National Heart, Lung, and Blood Institute (NHLBI)Myelodysplastic Syndromes (MDS)

Start: 2016-06-13End: 2025-12-31Updated: 2026-02-03

Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer

CompletedNCT02983279

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityBreast Carcinoma, Endometrial Carcinoma, Prostate Carcinosarcoma

Start: 2016-09-20End: 2022-12-29Updated: 2025-04-29

Related Papers

Multi-modal AI foundation models approach for diagnosis of myelodysplastic syndromes across whole bone marrow aspirate and biopsy slides.

Journal of Clinical Oncology2026-05-27

Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex.

2026-03-29

A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History Study

Blood Advances2026-02-11

Clinical, genetic, and pathologic differences across race, ethnicity, and sex in patients with MDS and precursor conditions from the national MDS natural history study

Blood2025-11-03

Artificial intelligence-based diagnosis of myelodysplastic syndromes/neoplasms using bone marrow

Blood2025-11-03

A Deep-Learning Pipeline for Diagnosis of Myelodysplastic Syndromes/Neoplasms Using Bone Marrow Smears

Blood2024-11-051 citations

Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies

Blood Advances2023-08-088 citations

Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study

Blood Advances2023-05-0512 citations

Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions

Blood Advances2023-03-227 citations

COVID-19 Outcomes Among Participants in the NHLBI Myelodysplastic Syndromes (MDS) Natural History Study

Blood2021-11-051 citations

Patient-Reported Outcomes and Frailty Among Participants in the NHLBI MDS Natural History Study

Blood2020-11-054 citations

Targeted Sequencing of 7 Genes Can Help Reduce Pathologic Misclassification of MDS

Blood2020-11-053 citations

Clonal Cytopenias of Undetermined Significance Are Common in Cytopenic Adults Evaluated for MDS in the National MDS Study

Blood2019-11-13

The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes

Leukemia & lymphoma/Leukemia and lymphoma2019-05-2113 citations

Diagnosis of Myelodysplastic Syndromes and Related Conditions: Rates of Discordance between Local and Central Review in the NHLBI MDS Natural History Study

Blood2018-11-295 citations